The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-1 blockade alone for mismatch repair deficient (dMMR) locally advanced rectal cancer.
 
Melissa Amy Lumish
No Relationships to Disclose
 
Jenna L. Cohen
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I)
 
Jill A Weiss
No Relationships to Disclose
 
Michelle F. Lamendola-Essel
Consulting or Advisory Role - Rockefeller University
 
Rona Yaeger
Consulting or Advisory Role - Array BioPharma; Mirati Therapeutics; Natera
Research Funding - Array BioPharma (Inst); Boehringer Ingelheim (Inst); Mirati Therapeutics (Inst); Pfizer (Inst)
 
Neil Howard Segal
Consulting or Advisory Role - ABL Bio; Aduro Biotech; Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; CStone Pharmaceuticals; GlaxoSmithKline; Gritstone Bio; Immunocore; Kyn therapeutics; Pieris Pharmaceuticals; PsiOxus Therapeutics; PureTech; Roche/Genentech; Synlogic; TRM Oncology
Research Funding - AstraZeneca; Bristol-Myers Squibb; Immunocore; Incyte; Merck; Pfizer; Roche/Genentech
 
Imane H. El Dika
Honoraria - Lynx Group
Consulting or Advisory Role - QED Therapeutics
Travel, Accommodations, Expenses - QED Therapeutics
 
Leonard B. Saltz
Research Funding - Taiho Pharmaceutical
 
Marina Shcherba
No Relationships to Disclose
 
Ryan Sugarman
No Relationships to Disclose
 
Avni Mukund Desai
No Relationships to Disclose
 
Jesse Joshua Smith
Consulting or Advisory Role - Guardant Health
 
Maria Widmar
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
 
Emmanouil Pappou
No Relationships to Disclose
 
Philip Paty
No Relationships to Disclose
 
Julio Garcia-Aguilar
Stock and Other Ownership Interests - Intuitive surgical
Consulting or Advisory Role - Intuitive Surgical; Johnson & Johnson; Medtronic
 
Martin R. Weiser
Consulting or Advisory Role - Precisca
Research Funding - Clinical Genomics
 
Luis A. Diaz
Leadership - Jounce Therapeutics; Personal Genome Diagnostics
Stock and Other Ownership Interests - Amgen (I); Delfi Diagnostics; Four Paws; Jounce Therapeutics; Kinnate Biopharma; Neophore; Personal Genome Diagnostics; Seer; Thrive Earlier Detection Corp; Zydecom
Consulting or Advisory Role - Four Paws; Innovatus Capital Partners; Kinnate Biopharma; Merck; Neophore; Personal Genome Diagnostics; Seer; Zydecom
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - EP-2912468-B1 - Papanicolaou test for ovarian and endometrial cancers; EP-3322824-A1 - Detection of tumor-derived dna in cerebrospinal fluid; US-2005202465-A1 - Thymidylate synthase gene and metastasis; US-2010041048-A1 - Circulating Mutant DNA to Assess Tumor Dynamics; US-2013323167-A1 - Detecting and treating solid tumors through selective disruption of tumor vasculature; US-2014227271-A1 - Somatic mutations in atrx in brain cancer; US-2015252415-A1 - Arid1b and neuroblastoma; US-2015344970-A1 - Personalized Tumor Biomarkers; US-2016208340-A1 - TERT Promoter Mutations in Urothelial Neoplasia; US-2016273049-A1 - Systems and methods for analyzing nucleic acid (Inst); US-2017016075-A1 - Neoantigen analysis (Inst); US-2017267760-A1 - Checkpoint Blockade and Microsatellite Instability; US-2018086832-A1 - Hla-restricted epitopes encoded by somatically mutated genes; US-2018135044-A1 - Non-unique barcodes in a genotyping assay (Inst); US-2018171413-A1 - Head and neck squamous cell carcinoma assays; US-2018171413-A1 - Head and neck squamous cell carcinoma assays; US-2018171413-A1 - Head and neck squamous cell carcinoma assays; US-2018258490-A1 - Assaying ovarian cyst fluid; US-9976184-B2 - Mutations in pancreatic neoplasms; WO-2010118016-A2 - Digital quantification of dna methylation; WO-2012094401-A2 - Genes frequently altered in pancreatic neuroendocrine tumors; WO-2018071796-A2 - Compositions and methods for identifying functional anti-tumor t cell responses
 
Andrea Cercek
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Incyte
Research Funding - Rgenix (Inst); Seagen; Tesaro